Repligen Corporation (RGEN) Dividend Analysis
This company has no dividend history.
Based on TTM and annual data · Not a buy/sell signal
This company does not pay dividends
No dividend history found in SEC filings.
Does Repligen (RGEN) pay a dividend?
Repligen (RGEN) has never paid a dividend. The business does generate free cash flow of $112 million, so the absence of a dividend is a capital-allocation choice rather than an inability to pay. All figures are computed from company filings; this is analysis, not investment advice.
Frequently asked
Does Repligen (RGEN) pay a dividend?+
No. Repligen (RGEN) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold.
How does Repligen return cash to shareholders?+
It largely does not. Repligen pays no dividend and we do not see a meaningful reduction in share count over the last twelve months, so cash is being retained in the business or spent on growth rather than returned. That is common for companies reinvesting heavily, and it means your return depends entirely on the share price.
Could Repligen afford to pay a dividend?+
On the numbers, yes. Repligen generated $112 million of free cash flow, which is about $1.98 per share. If it paid out half of that, the dividend would be roughly $0.99 per share, a yield of about 0.6% at the current price. That is an illustration of capacity, not a prediction: the company has given no indication it intends to pay one.
Which healthcare companies do pay dividends?+
Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with Repligen.
SourceDividend analysis computed from the 10-Q filed 24 Jul 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 30 Jul 2026. How this is calculated.
Fiscal year ends Dec. Earnings payout = dividends / net income. FCF payout = dividends / FCF. Yield = TTM DPS / price.
Related stocks: Biological Products, (No Diagnostic Substances)
Spot a number that looks wrong?
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.